Group 1: Financial Performance - The company achieved an annual revenue of 1,073.98 million yuan in 2024, with a net profit of 318.30 million yuan, representing a year-on-year growth of 9.64% [3] - The financial report indicates a positive performance aligned with the annual operational plan [3] Group 2: Business Development and Strategy - The company focuses on enhancing its polymer materials resource layout and strengthening functional material technology research and development to ensure sustainable business growth [3] - The company aims to provide competitive process solutions by integrating patented technologies with engineering design and management experience [3] - Future demand for nylon products is expected to increase in sectors such as rail transportation, power, electronics, and automotive components [3] Group 3: Innovation and Market Trends - The company is committed to breakthroughs in recycled materials and biodegradable materials, addressing quality bottlenecks in primary recycled products [3] - The chemical recycling method is prioritized for its advantages in processing textile waste, contributing to a comprehensive waste plastic recycling technology system [3] - The company is expanding its service capabilities in new materials and recycled materials, aiming to become a leading engineering service platform in these fields [4] Group 4: Industry Outlook - The company emphasizes innovation as a key driver for high-quality development and aims to maintain a competitive edge in both domestic and international markets [4] - The focus is on customized system integration solutions across various synthetic and recycled material industries, including PA6, PA66, rPET, and biodegradable materials [4]

Group 1: Financial Performance - The net profit attributable to shareholders decreased by 58.47% year-on-year, from over 21 million to over 9 million [1] - The decline in net profit was primarily due to depreciation from the completion of a high-barrier composite material project and the implementation of an employee stock ownership plan, impacting profits by over 6 million and over 3 million respectively [1][2] Group 2: Strategic Initiatives - The company aims to enhance performance through cost reduction, efficiency improvement, and increased R&D and market expansion efforts [2] - Future plans include strengthening information disclosure and investor communication while focusing on share repurchase and employee stock ownership initiatives [2] Group 3: Development Focus - The company is prioritizing the completion of its private placement and convertible bond projects to support future growth [3] - External growth through mergers and acquisitions is considered, but the company emphasizes the importance of technological and market synergies [3] Group 4: Product Development - A new division for high-performance medical film materials has been established, focusing on ostomy pouch films and high-end infusion films, with the latter being reliant on imports [3][4] - The company is also developing electronic materials, including UV adhesive tapes and PI high-temperature adhesive tapes, with some products already passing tests by downstream manufacturers [4] Group 5: Market Outlook - The aluminum-plastic film market is expected to grow significantly with the industrialization of solid-state batteries, with the company working on client certifications before market expansion [4] - The company has improved its thermal process technology for aluminum-plastic films and is preparing samples for clients [4]

编号：2025-03 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动类 | □媒体采访 ☑业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他（电话会议） | | 活动参与人员 | 接待对象：网上投资者 | | | 接待人员：公司董事长、总经理杨波先生、财务总监朱国友先生、董 | | | 事会秘书翟建峰先生 | | 时间 | 2025 年 5 月 16 日 (周五) 下午 16:00-17:00 | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | | 形式 | 网络远程 | | | 公司就投资者在本次说明会中提出的问题进行了回复，问答环节 | | | 主要内容如下： | | | 1、请问贵公司有没有涉及工业机器人业务，若涉及请问是什么 | | | 业务，是否有在售产品或生产线的搭建？ | | | 您好，目前公司除智能物流配送车外，无其他机器人业务。谢谢！ | | | 2、公司发动机可以间接用于航空或者无人机相关领域吗？ | | 交流内容及具体问 | 目前公司暂无航空和无人机发动机业务， ...

Group 1: Financial Performance and Goals - The company aims to achieve profitability by the second or third quarter of 2025, following a loss in the first quarter [2] - The target for the year is to turn losses into profits through improved operational efficiency and quality [2] Group 2: Order and Revenue Recognition - The typical manufacturing cycle for products ranges from 3 to 9 months, with revenue recognized upon customer acceptance of installation [2] - Domestic orders are confirmed based on the customer's signed acceptance of the installation [2] Group 3: Impact of Tariffs and Supply Chain - The impact of U.S. tariffs on sales is minimal, as exports to the U.S. constitute a small portion of overall revenue [3] - The company has a low dependency on direct imports from the U.S. and has developed self-sufficiency for core components [3] Group 4: International Business Development - In 2024, the company’s export orders exceeded 1 billion RMB for the first time, with significant growth in international markets [3] - The company has established sales service centers in over ten countries to enhance international business [3][4] Group 5: New Products and Business Expansion - The company has expanded its business into new sectors such as peptides, medical beauty, and blood products, achieving notable success [4] - The subsidiary, Chutian Huaton, has diversified its product offerings into emerging fields like wastewater treatment and new energy lithium batteries [4]

| | 特定对象调研 分析师会议 |  | | | --- | --- | --- | --- | | 投资者关系 | 媒体采访 业绩说明会 | | | | 活动类别 | 新闻发布会 路演活动 | | | | | 现场参观 其他 （电话会议） | | | | 参与单位名称及 | 宝盈基金 李巍宇、王灏、张若伦、李亚凡 | | | | 人员姓名 | 申万宏源证券 李秀琳、杨晓鸣 | | | | 时间 | 2025 年 月 日 | 5 | 16 | | 地点 | 公司会议室 | | | | 上市公司接待 | 副总经理兼董事会秘书许恬 | | | | 人员姓名 | | | | | 投资者关系活动 | 一、介绍环节 | | | | | 公司副总经理兼董事会秘书许恬就公司 2024 年度及 2025 年一季 | | | | | 度经营情况做了介绍。 | | | | | 二、问答环节 | | | | 主要内容介绍 | 公司在接待过程中严格按照公司《信息披露管理制度》《投资者 | | | | | 关系管理制度》规定，没有出现未公开重大信息泄露等情况。各方还 | | | | | 就公司品牌建设、产品研发等方面 ...

Financial Performance - In 2024, the company achieved a revenue of 627 million yuan, a year-on-year decrease of 35.71% [2] - The net profit attributable to shareholders was -214 million yuan, an increase of 56.76% year-on-year [2] - In Q1 2025, the company reported a revenue of 1.25 million yuan, a year-on-year decrease of 38.10%, while the net profit attributable to shareholders increased by 283.02% [2] Corporate Actions - The company is currently in the process of implementing relevant matters regarding the halted stock issuance [3][5] - There is ongoing uncertainty regarding the completion of the issuance before the deadline of August 12, 2025 [3][5] Industry Context - The banking sector, which is closely related to the company's business, is facing challenges such as a rapid narrowing of net interest margins, reaching historical lows [4] - Marketing budgets from banking clients are being managed cautiously, focusing more on the effectiveness and cost-performance of marketing efforts [4] Future Outlook - The company aims to enhance its market capabilities, solution capabilities, and operational capabilities while accelerating technological upgrades and promoting AI applications [3] - The company is also focused on optimizing its digital marketing service solutions and improving internal operational efficiency to strengthen long-term competitive barriers [3] Competitors - Key competitors in the industry include Fengzhushou (301382.SZ), Shijihengtong (301428.SZ), and Yuanlong Yatu (002878.SZ), although there are differences in main business and customer groups [4]

Economic Impact and Company Strategy - The domestic manufacturing sector faces challenges due to long cycles, with macroeconomic factors significantly impacting the company's performance [3] - The company has implemented measures to mitigate market risks and enhance profitability, particularly in energy-efficient motors and nuclear power products [4] - The company is focusing on developing first-level energy-efficient motors and has achieved certification for a new series, which is a key development priority for 2025 [7][8] Competitive Landscape - The company holds a dominant position in the helium compressor market, with only three suppliers in the domestic market [5] - The company is the fastest in delivery among competitors for its helium-related products [5] Export and Market Considerations - The company's electric motor products are primarily exported as part of larger machinery, resulting in a relatively low direct export ratio [6] - The company is exploring opportunities in the water conservancy sector, which is perceived to have more rational competition compared to the power industry [7] Future Product Development - The company is investing in R&D for new products, particularly in the nuclear power sector, where there is significant growth potential [4] - While the company has made preliminary technical preparations for servo motors used in robotics, it will continue to focus on specialized industrial motors as its main business [9] Investor Relations and Communication - The company is leveraging AI to enhance its investor relations and communication strategies, aiming to improve efficiency and quality in disseminating information [10] - Plans are in place to invite investors to visit subsidiaries for a more comprehensive understanding of the company's operations [10]

Industry Overview - The overall industry development shows a positive trend, driven by economic recovery and increased demand for consumer electronics, particularly in LCD TVs, computers, and new energy vehicles [2][3] - The display backlight module market is experiencing growth due to the recovery in demand for consumer electronics such as laptops and desktop monitors [3] Company Performance - In 2024, the company achieved a revenue of CNY 2.347 billion, representing a year-on-year increase of 8.49% [4] - The net profit attributable to shareholders was CNY -214 million, a significant decline of 505.70% compared to the previous year, primarily due to underutilization of new production lines and high fixed costs [4] R&D and Innovation - As of December 2024, the company holds a total of 410 registered patents, including 104 invention patents, and has authorized 322 patents, with 38 being invention patents [4] - R&D expenses increased by 11.53% year-on-year, focusing on high-end display technology breakthroughs to enhance technical barriers [5][6] Strategic Planning - The company aims to become the preferred partner in the semiconductor display industry, emphasizing sustainable development and enhancing core competitiveness [6] - Future strategies include continuous investment in R&D, expanding product categories, and improving customer engagement to increase market share [6]

Group 1: Company Overview and Financial Performance - Shenzhen Laibao High-Tech Co., Ltd. achieved a total sales revenue of 5.896 billion RMB in 2024, representing a year-on-year growth of 5.54% [3] - Sales revenue from notebook computer touch screens accounted for over 85% of the company's total sales revenue, while the automotive touch screen segment contributed less than 10% [3] Group 2: Market Trends and Future Projections - The global demand for notebook computer touch screens is expected to grow in 2025, driven by the end of Windows 10 upgrades and increasing demand for AI PC products [4] - TrendForce predicts that global notebook shipments will reach 183 million units in 2025, a year-on-year increase of 4.9% [4] Group 3: Automotive Touch Screen Business - The company's automotive touch screen clients include major manufacturers such as Changan, Geely, and Volkswagen [7] - The automotive touch screen segment is expected to continue growing in 2025, supported by the increasing demand for integrated display solutions in electric and smart vehicles [10] Group 4: Challenges and Competition - The company faces intensified competition from embedded structure touch screens, which may replace traditional capacitive touch screens [11] - The sales growth of notebook touch screens in 2025 is uncertain due to potential impacts from global economic conditions and consumer purchasing behavior [6] Group 5: Micro Electric Chamber Display (MED) Project - The MED project aims to capitalize on the growing market for large-size color electronic paper displays, with a total investment of 9 billion RMB [30] - The project is expected to enhance the company's core competitiveness and expand its international market presence [16] Group 6: Technical Development and Market Positioning - The MED products are designed for applications in electronic labels, e-readers, and various display terminals, focusing on low power consumption and eye protection [19] - The company plans to optimize the MED product's technical performance, including contrast and color saturation, to enhance market competitiveness [25] Group 7: Future Market Outlook - The global electronic paper display market is projected to reach 72.3 billion USD by 2025, with a compound annual growth rate of over 50% [23] - The demand for color electronic paper displays is expected to grow significantly, particularly in educational and advertising sectors [24]

Group 1: Company Strategy and Development - The company adheres to a dual strategy of independent and collaborative research and development, enhancing its long-term development through strategic investments and internal resource integration [1] - The company aims to become a trusted and preferred provider of professional healthcare products, focusing on a unified operational system across R&D, marketing, and production [2] - The company plans to implement a four-pronged growth model encompassing OTC, prescription drugs, traditional Chinese medicine, and health products to support high-quality development [2] Group 2: Marketing and Sales Achievements - The company has established a comprehensive marketing system, covering over 3,000 chain pharmacies and approximately 240,000 cooperative chain stores, reaching over 90% of cities and 70% of districts nationwide [2] - The company’s online channel strategy includes partnerships with e-commerce platforms to enhance product accessibility and consumer engagement [2] Group 3: Financial Performance - In 2024, the pharmaceutical segment generated revenue of 915 million yuan, accounting for 82.96% of total revenue, with the "Kuaike" series contributing 612 million yuan, representing 55.49% of total revenue [3] - The company’s cold and flu medications account for approximately 56% of total revenue [4] Group 4: Product Development and Market Position - The "Kuaike" cold medicine has ranked first in the annual comprehensive statistics of non-prescription drugs in China for three consecutive years from 2021 to 2023 [3] - The company has successfully launched the "Kuaike Qing" oseltamivir capsules and has received re-listing permits for other products [1] Group 5: Future Plans and Challenges - The company is actively preparing for the flu season by optimizing production capacity and ensuring smooth supply channels [5] - The company is exploring opportunities in traditional Chinese medicine, developing high-quality products to enhance market share in this sector [5]